HealthDay News — Among adults aged 45 to 49 years who are newly eligible for colorectal cancer (CRC) screening, there are no significant differences in screening uptake in adjusted analyses, according ...

We recently compiled a list of the 7 Most Promising Gene Editing Stocks According to Analysts. Guardant Health, Inc. is one ...

Lowering the CRC screening age to 45 resulted in a 955% increase in screenings among 45- to 49-year-olds. The increase was most notable among women, non-Hispanic Whites, and those with commercial ...

Colonoscopy conducted beyond 3 months and up to 24 months after a positive fecal immunochemical test are not linked to an ...

A novel, blood-based test developed using fragmentomic features of cell-free DNA (cfDNA) detects colorectal cancer (CRC) with a 90.4% sensitivity and shows consistent performance across stages and ...

Cases of colorectal cancer in younger adults are climbing worldwide, driven by lifestyle changes and inherited genetic risks.

Gastrointestinal tumors remain a global health challenge, with high incidence and mortality. Among them, colorectal cancer (CRC) carries the heaviest ...

Scientists studied factors such as viral infections, gut microbiome, and exposome that could drive cancers, as well as how to ...

RZV offers substantial clinical and economic benefits but has low uptake among adults aged 50 and older compared to other vaccines. By 2020, only 10.8% of adults aged 50 and older had completed both ...

Colorectal cancer is on the rise but the good news is, its highly prventable! Dr Jagiasi shares 5 strategies for Indians to lower the risk.

“Authorization of our full screening portfolio by the Egyptian Drug Authority represents a milestone in expanding access to early detection in a region with growing chronic disease and cancer burdens, ...

A liquid biopsy involving a half-dozen cell-free and exosome-based circulating biomarkers showed high specificity and sensitivity for detecting colorectal cancers (CRCs) and could aid in screening for ...